The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Quest Diagnostics, Inc shares valued at $5,731,302 were sold by PREVOZNIK MICHAEL E on Nov 29 ’24. At $163.07 per share, PREVOZNIK MICHAEL E sold 35,146 shares. The insider’s holdings dropped to 38,478 shares worth approximately $6.1 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Doherty Catherine T. sold 33,103 shares, netting a total of over 5,395,484 in proceeds. Following the sale of shares at $162.99 each, the insider now holds 68,412 shares.
Before that, PREVOZNIK MICHAEL E had added 35,146 shares to its account. In a trade valued at $5,731,302, the Officer bought Quest Diagnostics, Inc shares for $163.07 each.
As published in a research note from Robert W. Baird on October 23, 2024, Quest Diagnostics, Inc [DGX] has been rated up from a Neutral to an Outperform and the price target has been revised to $182 from $157. As of July 10, 2024, Citigroup has increased its “Neutral” rating to a “Buy” for DGX. Earlier on February 26, 2024, Leerink Partners initiated its rating. Their recommendation was “a Market perform” for DGX stock.
Analyzing DGX Stock Performance
During the last five days, there has been a drop of approximately -2.94%. Over the course of the year, Quest Diagnostics, Inc shares have jumped approximately 14.97%. Shares of the company reached a 52-week high of $165.32 on 11/25/24 and a 52-week low of $123.04 on 02/01/24. A 50-day SMA is recorded $156.00, while a 200-day SMA reached $144.21. Nevertheless, trading volume fell to 0.76 million shares from 9189.0 shares the previous day.
Support And Resistance Levels for Quest Diagnostics, Inc (DGX)
According to the 24-hour chart, there is a support level at 157.77, which, if violated, would cause prices to drop to 157.02. In the upper region, resistance lies at 159.67. The next price resistance is at 160.82. RSI (Relative Strength Index) is 47.06 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.58, which suggests the price will decrease in the coming days. Percent R is at 75.56%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
